Perceptive Advisors - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$7,889,000
-80.0%
100,000
-79.9%
0.40%
-85.9%
Q4 2016$39,527,000
+1317466.7%
498,198
-8.5%
2.81%
Q3 2016$3,000
-100.0%
544,770
+81.6%
0.00%
-100.0%
Q2 2016$11,637,000
+53.5%
300,000
+60.2%
0.81%
+21.4%
Q1 2016$7,582,000
-35.8%
187,215
+40.6%
0.66%
-23.8%
Q4 2015$11,806,000
-35.2%
133,145
-45.9%
0.87%
+19.9%
Q3 2015$18,218,000
-3.3%
246,088
+5.6%
0.73%
-35.9%
Q2 2015$18,844,000
+3624.1%
233,044
+1827.9%
1.14%
+2810.3%
Q1 2015$506,00012,0880.04%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 4,780,188$353,877,00083.76%
JW Asset Management, LLC 848,709$62,830,00022.76%
Consonance Capital Management LP 1,353,913$100,230,00014.10%
Cormorant Asset Management, LP 300,000$22,209,0003.55%
Park West Asset Management LLC 500,591$37,059,0003.38%
Opaleye Management Inc. 73,200$5,419,0002.67%
Ranger Investment Management 428,295$31,707,0001.79%
WALL STREET ASSOCIATES 119,900$8,876,0001.70%
Timpani Capital Management LLC 27,090$2,005,0000.81%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 22,375$1,656,0000.79%
View complete list of EAGLE PHARMACEUTICALS INC shareholders